A phase Ⅱ clinical trial for evaluating the efficacy and safety of dihydroxyaluminum aminoacetate-heavy magnesium carbonate-aspirin in inhibition of platelet aggregation

HUANG Yan; FAN Chao-mei; HU Da-yi; YANG Xin-chun; JIA San-qing; GAO Wei; HUANG Yi-ling; BIAN Wen-yan; LIU Wen-ling; DING Xiao-wei; ZHENG Ping-yu; HAN Jiang-li; LI Yi-shi

doi:10.3321/j.issn:1003-3734.2007.24.018

Home>Articles>A phase Ⅱ clinical trial for evaluating the efficacy and safety of dihydroxyaluminum aminoacetate-heavy magnesium carbonate-aspirin in inhibition of platelet aggregation

DOI: 10.3321/j.issn:1003-3734.2007.24.018

A phase Ⅱ clinical trial for evaluating the efficacy and safety of dihydroxyaluminum aminoacetate-heavy magnesium carbonate-aspirin in inhibition of platelet aggregation

HUANG Yan

FAN Chao-mei

HU Da-yi

YANG Xin-chun

JIA San-qing

GAO Wei

HUANG Yi-ling

BIAN Wen-yan

LIU Wen-ling

DING Xiao-wei

ZHENG Ping-yu

HAN Jiang-li

LI Yi-shi

Machine-generated Keywords：

Publication Date：2007-01-01

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：4( 2066-2068,2082 )

CHINESE JOURNAL OF NEW DRUGS

PKUISTIC

ISSN：1003-3734

Year, Vol.(Issue)：2007,16(24)